This research report titled ‘Global Women’s Health Market 2016-2020’, provides an in-depth analysis of market growth in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments, including postmenopausal, contraceptives, infertility, menopause, and endometriosis.
Request sample report: http://bit.ly/1VneRTp
“Compared to developed nations, developing and underdeveloped countries have a lack of technologies and an unavailability of certain facilities. A woman in a developing country is 97 times more likely to die during childbirth compared to one in a developed country. According to WHO, postpartum hemorrhage, which is the loss of 500ml-1,000ml of blood within 24 hours after birth, accounts for over a quarter of maternal deaths in most of the developing countries,” said Barath Palada, one of Technavio’s lead analysts for health and wellness research.
Firms are developing various lifesaving technologies to overcome these challenges, including the following:
- Advanced devices to deliver a baby safely during an obstructed labor
- Antiretroviral drugs to prevent HIV
- Vital nutrition supplements for pregnant women.
- Mobile technologies to provide health workers across the globe with diagnostic tests, protocols, and screenings to be undertaken
- A non-pneumatic anti-shock garment such as Neoprene and Velcro has been used experimentally by health experts to counter postpartum hemorrhage. The garment is wrapped around a woman’s lower legs and abdomen to slow down the bleeding and to prevent shock due to blood loss.
Global women's health market segmentation by application 2015
- Postmenopausal 37.63%
- Contraceptives 34.04%
- Infertility 10.81%
- Menopause 10.61%
- Endometriosis 5.01%
Global postmenopausal osteoporosis market: largest segment
The global postmenopausal osteoporosis market was valued at USD 10.9 billion in 2015. The postmenopausal osteoporosis market will grow moderately during the forecast period due to the increase in the population of older women. According to the International Osteoporosis Foundation, it is estimated that approximately 200 million women will be affected by postmenopausal osteoporosis globally. One-tenth of women aged 60, one-fifth aged 70, two-fifths aged 80, and two-thirds aged 90 will be diagnosed with osteoporosis in the coming years.
The increasing CAGR in the postmenopausal osteoporosis market can also be attributed to growing healthcare spending and improvement in healthcare infrastructure globally, which is anticipated to offer various benefits for firms investing in the market during the forecast period.
Global contraceptives market: second largest market
The global contraceptives market was valued at USD 9.86 billion in 2015. The contraceptives portfolio includes drugs and devices such as female condoms, copper hormonal IUD, vaginal rings, subdermal implants, and others. Condoms are non-hormonal contraceptives that play an important role in controlling STIs and preventing unwanted pregnancies. Cervical caps, sponges, non-hormonal IUDs, and diaphragms are some other non-hormonal contraceptive methods.
Some hormonal contraceptive methods use synthetic sex hormones, estrogen, progestin, or a combination of both to prevent ovulation and to thicken women's cervical mucus. These include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. In some countries such as the US, France, and Spain, women use hormonal contraceptive methods to maintain healthy levels of sex hormones in their body required for sexual activities. The awareness and visibility of various types of contraceptives have largely increased, and with growing government initiatives, the demand is expected to grow in the coming years.
Global infertility market
The global infertility market was valued at USD 3.13 billion in 2015. The infertility market is one of the fastest growing segments in the women's health market. According to reports published by WHO in 2012, one in every four couples in developed countries had been affected by infertility. A report published by the Centers for Disease Control and Prevention states that, in the US, during 2014-2015, 6% of married women aged 15-44 were infertile and over 7.4 million women used infertility services.
A major factor influencing the infertility market is an increase in the age at which women are getting pregnant. With better access to education and employment, women are increasingly becoming career oriented. This often leads to a delay in planning a pregnancy. After a certain age, the probability of conceiving reduces, and in some cases results in infertility.
Browse related reports:
- Global Contraceptive Devices Market 2015-2019
- Global Osteoporosis Drugs Market 2015-2019
- Global Feminine Hygiene Wash Market 2016-2020
- Global Feminine Wipes Market 2016-2020
Purchase any three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact email@example.com with your requirements and a link to our subscription platform.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.